Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02684058
Title Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries USA | SWE | NLD | ITA | ISR | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CHE | CAN | BRA | BEL | AUS | ARG

Facility Status City State Zip Country Details
Children's Hospital of Orange County Orange California 92868 United States Details
Childrens National Hospital Washington District of Columbia 20010 United States Details
Nicklaus Childrens Hospital Miami Florida 33155 United States Details
Ann and Robert H Lurie Childrens Hospital of Chicago . Chicago Illinois 60611 United States Details
Indiana University School of Medicine . Indianapolis Indiana 46202-2810 United States Details
Johns Hopkins University IDS Pharmacy John Hopkins Hospital Baltimore Maryland 21287 United States Details
Washington University School of Medicine SC Saint Louis Missouri 63110 United States Details
Cincinnati Childrens Hospital Medical Center Cancer & Blood Disease Inst. Cincinnati Ohio 45229-3039 United States Details
St Jude Children's Research Hospital Memphis Tennessee 38105 United States Details
Texas Children s Hospital Baylor College of Medicine Houston Texas 77030 United States Details
Novartis Investigative Site Caba Buenos Aires C1428AQK Argentina Details
Novartis Investigative Site Randwick New South Wales 2130 Australia Details
Novartis Investigative Site Parkville Victoria 3052 Australia Details
Novartis Investigative Site Brussels BE-B-1200 Belgium Details
Novartis Investigative Site Barretos SP 14784 400 Brazil Details
Novartis Investigative Site Sao Paulo SP 04829-310 Brazil Details
Novartis Investigative Site Sao Paulo SP 08270-070 Brazil Details
Novartis Investigative Site Vancouver British Columbia V6H 3V4 Canada Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1C5 Canada Details
Novartis Investigative Site Brno 613 00 Czechia Details
Novartis Investigative Site Praha 5 150 06 Czechia Details
Novartis Investigative Site Copenhagen 2100 O Denmark Details
Novartis Investigative Site Tampere 33521 Finland Details
Novartis Investigative Site Lille Cedex 59020 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Strasbourg 67000 France Details
Novartis Investigative Site Toulouse Cedex 31059 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Augsburg 86179 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Gottingen 37075 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Petach-Tikva 49202 Israel Details
Novartis Investigative Site Tel-Hashomer 52621 Israel Details
Novartis Investigative Site Firenze FI 50139 Italy Details
Novartis Investigative Site Genova GE 16147 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Roma RM 00165 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Setagaya-ku Tokyo 157-8535 Japan Details
Novartis Investigative Site Osaka 534-0021 Japan Details
Novartis Investigative Site Utrecht CS 3584 Netherlands Details
Novartis Investigative Site Moscow 117198 Russian Federation Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Stockholm 17176 Sweden Details
Novartis Investigative Site Zuerich 8032 Switzerland Details
Novartis Investigative Site Leeds LS1 3EX United Kingdom Details
Novartis Investigative Site Liverpool L12 2AP United Kingdom Details
Novartis Investigative Site London WC1N 3JH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field